


Pharmaceuticals & Biotechnology | Small Cap
IOL Chemicals & Pharmaceuticals Ltd demonstrates a mixed financial performance. The company exhibits exceptional solvency, indicating a strong ability to meet its long-term obligations. Profitability is a notable strength, driven by healthy margins and returns on capital, equity, and assets. However, growth metrics present significant challenges, with declines in revenue, operating profit, EPS, and net income. Efficiency ratios also raise concerns, reflecting issues in asset utilization and working capital management. While liquidity is reasonable, it could be improved. The company's coverage ratios are strong, suggesting a good capacity to handle interest and dividend payments. Overall, IOL Chemicals & Pharmaceuticals showcases financial stability and profitability but needs to address its growth and efficiency to ensure sustained success. The healthcare industry's dynamics, including regulatory changes and market competition, could impact the company's future performance.
IOL Chemicals & Pharmaceuticals Ltd demonstrates a mixed financial performance. The company exhibits exceptional solvency, indicating a strong ability to meet its long-term obligations. Profitability is a notable strength, driven by healthy margins and returns on capital, equity, and assets. However, growth metrics present significant challenges, with declines in revenue, operating profit, EPS, and net income. Efficiency ratios also raise concerns, reflecting issues in asset utilization and working capital management. While liquidity is reasonable, it could be improved. The company's coverage ratios are strong, suggesting a good capacity to handle interest and dividend payments. Overall, IOL Chemicals & Pharmaceuticals showcases financial stability and profitability but needs to address its growth and efficiency to ensure sustained success. The healthcare industry's dynamics, including regulatory changes and market competition, could impact the company's future performance.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
34.79
Industry Median
30.92
Small Cap Median
28.82
P/E RATIO
34.79
P/B RATIO
2.66
Industry Median
3.39
Small Cap Median
2.92
P/S RATIO
2.02
Industry Median
3.36
Small Cap Median
2.72
Others
PEG RATIO
-7.25
EV/EBITDA RATIO
16.10
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹163.18 as on Aug 6, 2026.
The growth ratios present a concerning picture of the company's recent performance. Revenue, operating profit, EPS, and net income have all experienced declines, indicating significant challenges in expanding the business. The asset growth rate is positive, suggesting some level of investment, but this is overshadowed by the negative trends in other key growth metrics. The company needs to address these issues to regain positive momentum.
| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 1.51 | -3.79 | -2.53 | 11.54 | |
| Operating Profit Growth Rate | -12.74 | 2.21 | -12.55 | 33.17 | |
| Earnings Per Share (EPS) Growth | -16.99 | -3.38 | -24.89 | 36.34 | |
| Asset Growth Rate | 3.06 | 10.98 | 6.15 | 8.61 | |
| Net Income Growth Rate | -17.26 | -3.6 | -24.63 | 36.63 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Jagsonpal Pharmaceuticals Ltd | 8.51 | 37.02 | Overvalued | 58.00 | 6.54 | 43.00 |
| 2 | Amrutanjan Health Care Ltd | 8.25 | 73.76 | Highly Overvalued | 31.00 | 20.03 | 21.00 |
| 3 | Windlas Biotech Ltd | 7.52 | 27.76 | Neutral | 105.00 | 32.19 | 66.00 |
| 4 | Innova Captab Ltd | 7.36 | 38.74 | Overvalued | 243.00 | 14.63 | 141.00 |
| 5 | Aarti Drugs Ltd | 7.20 | 19.23 | Undervalued | 309.00 | 18.54 | 195.00 |
| 6 | Hikal Ltd | 7.13 | -55.92 | Neutral | 220.00 | -3.95 | -49.00 |
| 7 | RPG Life Sciences Ltd | 7.12 | 38.61 | Neutral | 147.00 | 69.64 | 115.00 |
| 8 | Morepen Laboratories Ltd | 7.12 | 45.91 | Neutral | 126.00 | 1.21 | 96.00 |
| 9 | Alembic Ltd | 7.06 | 7.01 | Undervalued | 90.00 | 4.85 | 317.00 |
| 10 | Syncom Formulations (India) Ltd | 6.92 | 16.27 | Undervalued | 77.00 | 0.81 | 76.00 |
| 11 | Hester Biosciences Ltd | 6.54 | 37.59 | Neutral | 87.00 | 61.24 | 57.00 |
| 12 | Sigachi Industries Ltd | 6.49 | 11.55 | Highly Undervalued | 54.00 | -2.08 | -83.00 |
| 13 | SMS Pharmaceuticals Ltd | 5.94 | 32.80 | Neutral | 171.00 | 9.35 | 102.00 |
| 14 | Gufic BioSciences Ltd | 5.49 | 63.18 | Neutral | 151.00 | 6.30 | 64.00 |
| 15 | Dishman Carbogen Amcis Ltd | 5.38 | 31.30 | Neutral | 566.00 | -2.45 | 97.00 |
| 16 | IOL Chemicals & Pharmaceuticals Ltd | 5.31 | 34.79 | Undervalued | 269.00 | 4.69 | 138.00 |
| 17 | Indoco Remedies Ltd | 5.26 | -21.52 | Neutral | 142.00 | -0.61 | -99.00 |
| 18 | Orchid Pharma Ltd | 4.85 | 246.31 | Neutral | 41.00 | 8.91 | 21.00 |
| 19 | Solara Active Pharma Sciences Ltd | 4.34 | -249.32 | Neutral | 187.00 | -1.50 | -7.00 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish